Predicting the Risk of Cardiovascular Disease: Where Does Lipoprotein-Associated Phospholipase A2 Fit In?

Author： Khuseyinova Natalie   Koenig Wolfgang  

Publisher： Adis International

ISSN： 1177-1062

Source： Molecular Diagnosis & Therapy, Vol.11, Iss.4, 2007-01, pp. : 203-217

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Role of Lipoprotein-Associated Phospholipase A2 (Lp-PLA2) in Cardiovascular Disease

By  

Reviews on Recent Clinical Trials, Vol. 6, Iss. 2, 2011-05 ,pp. : 108-113

Bentham Science Publishers

Access to resources Recommend Favorite

Lipoprotein associated phospholipase A 2 : role in atherosclerosis and utility as a biomarker for cardiovascular risk

By Colley Kenneth  

The EPMA Journal, Vol. 2, Iss. 1, 2011-03 ,pp. : 27-38

Springer Publishing Company

Access to resources Recommend Favorite

Lipoprotein‐associated phospholipase A2 levels are associated with erectile dysfunction in patients without known coronary artery disease

By  

ANDROLOGIA (ELECTRONIC), Vol. 47, Iss. 6, 2015-08 ,pp. : 706-710

John Wiley & Sons Inc

Access to resources Recommend Favorite

Does childhood nutrition influence adult cardiovascular disease risk?-Insights from the Young Finns Study

By Kaikkonen Jari E.  

Annals of Medicine, Vol. 45, Iss. 2, 2013-03 ,pp. : 120-128

Informa Healthcare

Access to resources Recommend Favorite

Lipoprotein-Associated Phospholipase A2: Review of its Role as a Marker and a Potential Participant in Coronary Endothelial Dysfunction

By Lavi Shahar  

Molecular Diagnosis & Therapy, Vol. 11, Iss. 4, 2007-01 ,pp. : 219-226

Adis International

Access to resources Recommend Favorite